P&G in China
This article was originally published in The Tan Sheet
Executive Summary
Firm announces $1.8 bil. purchase of remaining 20% stake in China joint venture from partner Hutchison Whampoa China. The deal was announced May 11 and is expected to close June 18. CEO A.G. Lafley said "it is the right time for us to assume full ownership" of the China venture, and that recent positive results demonstrate P&G has the "in-depth understanding of local consumers and retailers in China to continue to build this fast-growing business." China is one area where P&G has sought to localize its supply chain, marketing and management (1"The Tan Sheet" May 3, 2004, p. 6)...
You may also be interested in...
P&G Leverages Prilosec OTC, Oral Care Products To Increase Market Leads
Procter & Gamble's Prilosec OTC has garnered nearly a quarter share of the over-the-counter stomach remedy category
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.